HCM
TTPH

Highbridge Capital Management’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Highbridge Capital Management’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-660
Closed -$484K – 1772
2015
Q1 		$484K Buy
+660
New +$496K 0.01% 978

Other funds holding TTPH

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Highbridge Capital Management's TTPH Position: Q1 2016 in Review

Highbridge Capital Management sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q1 2016, closing a stake of 2,327 shares — an estimated $466K sold.

Highbridge Capital Management first reported a position in TTPH in Q4 2014 and held it in 3 quarters. The position peaked at $466K in Q4 2015. 101 funds tracked by Wall St. Rank hold TTPH as of Q1 2016.

  • Highbridge Capital Management reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
  • Highbridge Capital Management sold 2,327 Tetraphase Pharmaceuticals, Inc. shares in Q1 2016, an estimated $466K.
  • Highbridge Capital Management first reported a position in Tetraphase Pharmaceuticals, Inc. in Q4 2014 and held it in 3 quarters.
  • Highbridge Capital Management's Tetraphase Pharmaceuticals, Inc. position peaked at $466K in Q4 2015.
  • 101 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q1 2016.

Based on Highbridge Capital Management's 13F filing for Q1 2016, filed 16 May 2016.